Related Experiment Video
Updated: Dec 28, 2025

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
Plasma BNP Levels and Diuretics Use as Predictors of Cardiovascular Events in Patients with Myocardial Infarction and
Kazuhiro Shindo1, Hiroki Fukuda1, Tatsuro Hitsumoto1
1Department of Clinical Research and Development, National Cerebral and Cardiovascular Center, 6-1 Kishibe-Shinmachi, Suita, Osaka, Japan.
Insights
High plasma BNP levels predict cardiovascular events like heart failure and myocardial infarction in patients with impaired glucose tolerance. Diuretic use also predicts these events but not coronary stenosis progression.
Area of Science:
- Cardiology
- Endocrinology
- Medical Informatics
Background:
- Impaired glucose tolerance (IGT) is a risk factor for cardiovascular events.
- Alpha-glucosidase inhibitors did not prevent cardiovascular events in patients with myocardial infarction (MI) and IGT in the ABC study.
- Identifying clinical factors for cardiovascular events in MI patients with IGT is crucial.
Purpose of the Study:
- To identify clinical factors predicting cardiovascular events in patients with myocardial infarction (MI) and impaired glucose tolerance (IGT).
Main Methods:
- Utilized an artificial intelligence (AI)-based data mining method, the limitless-arity multiple testing procedure.
- Analyzed 385,391 combinations of fewer than four clinical parameters in 853 patients.
- Verified findings using Kaplan-Meier curves.
Main Results:
- Identified 380 predictive combinations for hospitalization (all-cause, heart failure, non-fatal MI) and revascularization (PCI/CABG).
- Plasma BNP levels ≥ 200 pg/dl or diuretic use predicted all-cause hospitalization, worsening heart failure, and non-fatal MI.
- Plasma BNP levels ≥ 200 pg/dl uniquely predicted hospitalization for PCI/CABG, indicating a role in coronary stenosis progression.
Conclusions:
- High plasma BNP levels predict coronary stenosis, recurrent MI, and worsening heart failure in MI patients with IGT.
- Diuretic use predicts non-fatal MI and worsening heart failure but not coronary stenosis progression.
- Plasma BNP levels are a key predictor of adverse cardiovascular outcomes and need for revascularization in this patient group.
Purpose:
Although impaired glucose tolerance (IGT) promotes cardiovascular events, our Alpha-glucosidase-inhibitor Blocks Cardiac Events in Patients with Myocardial Infarction and Impaired Glucose Tolerance (ABC) study showed that alpha-glucosidase inhibitors do not prevent cardiovascular events in patients with myocardial infarction (MI) and IGT. The aim of the present study was to identify potential clinical factors for cardiovascular events in patients with MI and IGT.
Methods:
Using the limitless-arity multiple testing procedure, an artificial intelligence (AI)-based data mining method, we analyzed 385,391 combinations of fewer than four clinical parameters.
Results:
We identified 380 combinations predicting the occurrence of (1) all-cause hospitalization, (2) hospitalization due to worsening of heart failure (HF), (3) hospitalization due to non-fatal MI, and (4) hospitalization due to percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) for stable angina among 385,391 combinations in 853 patients. Among these, either plasma BNP levels ≥ 200 pg/dl or diuretic use exclusively predicted (1) all-cause hospitalization, (2) hospitalization due to worsening of HF, and (3) hospitalization due to a non-fatal MI, with plasma BNP levels ≥ 200 pg/dl being the sole predictor of hospitalization due to PCI and CABG. Importantly, each finding was verified by independently drawn Kaplan-Meier curves, revealing the unexpected role of plasma BNP levels in the progression of coronary stenosis determined as the necessity of PCI and CABG for stable angina.
Conclusions:
In patients with MI and IGT, high plasma BNP levels predicted the occurrence of coronary stenosis, recurrent MI, and worsening of HF, whereas diuretic use did not predict the progression of coronary stenosis but non-fatal MI and worsening of HF.
More Related Videos
04:41Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease
Published on: July 3, 2018
10:21Evaluation of Hydration Status by Bioelectrical Impedance Vector Analysis in Patients with Ischemic Heart Disease Undergoing Exercise Stress Test
Published on: September 22, 2023
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Dipeptidyl Peptidase 4 Inhibitors
Heart Failure Drugs: Diuretics
Antihypertensive Drugs: Action of Diuretics
Serum Studies: Renal Function Tests
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...